FDA Considers National Registry For Silicone Breast Implants
This article was originally published in The Gray Sheet
Executive Summary
Due to lower-than-expected follow-up rates for Allergan and Johnson & Johnson/Mentor’s silicone-gel-filled breast implant post-approval studies, FDA advisory panel members last week called for a national registry to better document long-term outcomes and complications.You may also be interested in...
Breast Implant Makers Can Use Registries To Fulfill Post-Market Surveillance Duties
After years of struggling to track breast implant patients with post-market surveillance surveys, silicone gel breast implant makers will be allowed by FDA to substitute data from two new registries to fulfill their duties on post-approval studies and device tracking, an FDA epidemiologist said recently.
Ideal Implant Aims For Saline Breast Implant With Natural-Tissue Feel
Start-up firm Ideal Implant aims to compete in the lucrative breast implant market with a novel design offering the safety of saline and the natural feel of silicone gel, according to founder and president Robert Hamas.
Ideal Implant Aims For Saline Breast Implant With Natural-Tissue Feel
Start-up firm Ideal Implant aims to compete in the lucrative breast implant market with a novel design offering the safety of saline and the natural feel of silicone gel, according to founder and president Robert Hamas.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: